These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6444696)

  • 1. Proliferation of T gamma cells with killer-cell activity in two patients with neutropenia and recurrent infections.
    Bom-van Noorloos AA; Pegels HG; van Oers RH; Silberbusch J; Feltkamp-Vroom TM; Goudsmit R; Zeijlemaker WP; von dem Borne AE; Melief CJ
    N Engl J Med; 1980 Apr; 302(17):933-7. PubMed ID: 6444696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferation of T gamma cells with killer-cell activity in patients with neutropenia.
    Ault KA; Smith BR; Holmberg LA
    N Engl J Med; 1980 Oct; 303(15):881-2. PubMed ID: 6968034
    [No Abstract]   [Full Text] [Related]  

  • 3. Proliferation of T gamma cells with killer-cell activity in patients with neutropenia.
    Brouet JC
    N Engl J Med; 1980 Oct; 303(15):882. PubMed ID: 6968035
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytopenia and T cell proliferation.
    Beverley PC; Linch DC; Callard RE; Worman CP; Cawley JC
    J Clin Immunol; 1982 Jul; 2(3 Suppl):135S-141S. PubMed ID: 6215425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T gamma lymphocytosis is clinically non-progressive but immunologically heterogeneous.
    Miedema F; Terpstra FG; Smit JW; van der Veen JP; Melief CJ
    Clin Exp Immunol; 1985 Aug; 61(2):440-9. PubMed ID: 2931225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional properties of T cells in patients with chronic T gamma lymphocytosis and chronic T cell neoplasia.
    Rümke HC; Miedema F; ten Berge IJ; Terpstra F; van der Reijden HJ; van de Griend RJ; de Bruin HG; von dem Borne AE; Smit JW; Zeijlemaker WP; Melief CJ
    J Immunol; 1982 Jul; 129(1):419-26. PubMed ID: 6211484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronic granulocytopenia as a main symptom of T gamma-lymphocytosis].
    Krieger G; Kneba M; Ohms G; Gabius S; Nagel GA
    Dtsch Med Wochenschr; 1989 Jul; 114(27):1064-8. PubMed ID: 2525466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both Fc receptors and lymphocyte-function-associated antigen 1 on human T gamma lymphocytes are required for antibody-dependent cellular cytotoxicity (killer cell activity).
    Miedema F; Tetteroo PA; Hesselink WG; Werner G; Spits H; Melief CJ
    Eur J Immunol; 1984 Jun; 14(6):518-23. PubMed ID: 6610556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subpopulations of T lymphocytes and non-specific suppressor cell activity in patients with atopic dermatitis.
    Jensen JR; Cramers M; Thestrup-Pedersen K
    Clin Exp Immunol; 1981 Jul; 45(1):118-23. PubMed ID: 6458433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unusual phenotype and function of an expanded subpopulation of T cells in patients with haemopoietic disorders.
    Callard RE; Smith CM; Worman C; Linch D; Cawley JC; Beverley PC
    Clin Exp Immunol; 1981 Mar; 43(3):497-505. PubMed ID: 7026093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NK cell function in severe combined immunodeficiency (SCID): evidence of a common T and NK cell defect in some but not all SCID patients.
    Peter HH; Friedrich W; Dopfer R; Müller W; Kortmann C; Pichler WJ; Heinz F; Rieger CH
    J Immunol; 1983 Nov; 131(5):2332-9. PubMed ID: 6415162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferation of T gamma cells with killer-cell activity in patients with neutropenia.
    Ceuppens J
    N Engl J Med; 1980 Oct; 303(15):882. PubMed ID: 6447834
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies of human natural killer cells. III. Neutropenia associated with unusual characteristics of antibody-dependent and natural killer cell-mediated cytotoxicity.
    Pross HF; Pater J; Dwosh I; Giles A; Gallinger LA; Rubin P; Corbett WE; Galbraith P; Baines MG
    J Clin Immunol; 1982 Apr; 2(2):126-34. PubMed ID: 6978346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Migratory capacity of large granular lymphocytes from T-gamma-lymphoproliferative disorders.
    Bottazzi B; Rambaldi A; Introna M; Merendino A; Piovella F; Bassan R; Viero P; Barbui T; Mantovani A
    Nat Immun Cell Growth Regul; 1986; 5(1):19-27. PubMed ID: 2939337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The functional activity of Fc gamma RII and Fc gamma RIII on subsets of human lymphocytes.
    Hadley AG; Zupanska B; Kumpel BM; Leader KA
    Immunology; 1992 Jul; 76(3):446-51. PubMed ID: 1356095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel T cell population with antitumor activity expresses a gamma-CD3 receptor: applicability for immunotherapy.
    Bolhuis RL; Stoter G; van de Griend RJ
    Prog Clin Biol Res; 1987; 244():233-49. PubMed ID: 2958870
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulations.
    Moutsopoulos HM; Fauci AS
    J Clin Invest; 1980 Feb; 65(2):519-28. PubMed ID: 6444308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressor cell-mediated neutropenia in Felty's syndrome.
    Abdou NI; NaPombejara C; Balentine L; Abdou NL
    J Clin Invest; 1978 Mar; 61(3):738-43. PubMed ID: 305925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [T-cell bearing IgG-Fc receptor in patients with bladder cancer].
    Sakai S; Kato N; Ishiyama S; Deguchi T; Fujimoto Y; Muranaka K; Matsuda S; Fujihiro S; Setsuda O; Nishiura T
    Hinyokika Kiyo; 1983 Dec; 29(12):1625-9. PubMed ID: 6610295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Change of T gamma, T mu cells and its clinical implications in cervical cancer].
    Mori H
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Nov; 34(11):1883-8. PubMed ID: 6217264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.